Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma
Modern Pathology, Published online: 15 August 2022; doi:10.1038/s41379-022-01126-3Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma (Source: Modern Pathology)
Source: Modern Pathology - August 15, 2022 Category: Pathology Authors: Matthew Margolis Tyler Janovitz Jason Laird Douglas A. Mata Meagan Montesion Jessica K. Lee Russell W. Madison Alexa B. Schrock Hanna Tukachinsky Justin M. Allen Rachel Erlich Matthew C. Hiemenz Richard S. P. Huang Julia Elvin Jo-Anne Vergilio Douglas I. Source Type: research
Integrating artificial intelligence in pathology: a qualitative interview study of users’ experiences and expectations
Modern Pathology, Published online: 04 August 2022; doi:10.1038/s41379-022-01123-6Integrating artificial intelligence in pathology: a qualitative interview study of users’ experiences and expectations (Source: Modern Pathology)
Source: Modern Pathology - August 4, 2022 Category: Pathology Authors: Jojanneke Drogt Megan Milota Shoko Vos Annelien Bredenoord Karin Jongsma Source Type: research
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer
Modern Pathology, Published online: 03 August 2022; doi:10.1038/s41379-022-01135-2Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (Source: Modern Pathology)
Source: Modern Pathology - August 3, 2022 Category: Pathology Authors: Maxim De Schepper Anne Vincent-Salomon Matthias Christgen Karen Van Baelen Fran çois Richard Hitoshi Tsuda Sasagu Kurozumi Maria Jose Brito Gabor Cserni Stuart Schnitt Denis Larsimont Janina Kulka Pedro Luis Fernandez Paula Rodr íguez-Martínez Ana Aula Source Type: research
The effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer
Modern Pathology, Published online: 01 August 2022; doi:10.1038/s41379-022-01139-yThe effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer (Source: Modern Pathology)
Source: Modern Pathology - August 1, 2022 Category: Pathology Authors: Philipp Zens Corina Bello Amina Scherz Michael von Gunten Adrian Ochsenbein Ralph A. Schmid Sabina Berezowska Source Type: research
Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations
Modern Pathology, Published online: 28 July 2022; doi:10.1038/s41379-022-01083-xDeriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations (Source: Modern Pathology)
Source: Modern Pathology - July 28, 2022 Category: Pathology Authors: Stephanie E. Siegmund Danielle K. Manning Phani K. Davineni Fei Dong Source Type: research
Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis
Modern Pathology, Published online: 27 July 2022; doi:10.1038/s41379-022-01108-5Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis (Source: Modern Pathology)
Source: Modern Pathology - July 27, 2022 Category: Pathology Authors: Mahul B. Amin Jesse K. McKenney Guido Martignoni Steven C. Campbell Sumanta Pal Satish K. Tickoo Source Type: research
Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?
Modern Pathology, Published online: 23 July 2022; doi:10.1038/s41379-022-01100-zMucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities? (Source: Modern Pathology)
Source: Modern Pathology - July 23, 2022 Category: Pathology Authors: Valerie A. White Martin D. Hyrcza Jochen K. Lennerz Julia Thierauf Dilani Lokuhetty Ian A. Cree Blanca Iciar Indave Source Type: research
Identification of fusions with potential clinical significance in melanoma
Modern Pathology, Published online: 23 July 2022; doi:10.1038/s41379-022-01138-zIdentification of fusions with potential clinical significance in melanoma (Source: Modern Pathology)
Source: Modern Pathology - July 23, 2022 Category: Pathology Authors: Jakob M. T. Moran Long P. Le Valentina Nardi Josephine Golas Alexander A. Farahani Sylvia Signorelli Maristela L. Onozato Ruth K. Foreman Lyn M. Duncan Donald P. Lawrence Jochen K. Lennerz Dora Dias-Santagata Mai P. Hoang Source Type: research
Intratumoral spatial heterogeneity of tumor-infiltrating lymphocytes is a significant factor for precisely stratifying prognostic immune subgroups of microsatellite instability-high colorectal carcinomas
Modern Pathology, Published online: 22 July 2022; doi:10.1038/s41379-022-01137-0Intratumoral spatial heterogeneity of tumor-infiltrating lymphocytes is a significant factor for precisely stratifying prognostic immune subgroups of microsatellite instability-high colorectal carcinomas (Source: Modern Pathology)
Source: Modern Pathology - July 22, 2022 Category: Pathology Authors: Minsun Jung Ji Ae Lee Seung-Yeon Yoo Jeong Mo Bae Gyeong Hoon Kang Jung Ho Kim Source Type: research
Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms
Modern Pathology, Published online: 21 July 2022; doi:10.1038/s41379-022-01133-4Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms (Source: Modern Pathology)
Source: Modern Pathology - July 21, 2022 Category: Pathology Authors: Martina Haberecker Marco Matteo B ühler Alicia Pliego Mendieta Roman Guggenberger Fabian Arnold Eva Markert Markus Rechsteiner Martin Zoche Christian Britschgi Chantal Pauli Source Type: research
Inside the USCAP Journals
Modern Pathology, Published online: 19 July 2022; doi:10.1038/s41379-022-01132-5Inside the USCAP Journals (Source: Modern Pathology)
Source: Modern Pathology - July 19, 2022 Category: Pathology Source Type: research
Molecular assessment of paratesticular rhabdomyomas demonstrates recurrent findings, including a novel H3C2 p.K37I mutation
Modern Pathology, Published online: 16 July 2022; doi:10.1038/s41379-022-01134-3Molecular assessment of paratesticular rhabdomyomas demonstrates recurrent findings, including a novel H3C2 p.K37I mutation (Source: Modern Pathology)
Source: Modern Pathology - July 16, 2022 Category: Pathology Authors: Andres M. Acosta Jesse K. McKenney Lynette M. Sholl Brendan C. Dickson Andres Matoso Haiyan Lu Vickie Y. Jo Katrina Collins Thomas M. Ulbright Christopher D. M. Fletcher Source Type: research
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer
Modern Pathology, Published online: 16 July 2022; doi:10.1038/s41379-022-01130-7ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer (Source: Modern Pathology)
Source: Modern Pathology - July 16, 2022 Category: Pathology Authors: Isabel Grote Stephan Bartels Henriette Christgen Martin Radner Malte Gronewold Leonie Kandt Mieke Raap Ulrich Lehmann Oleg Gluz Monika Graeser Sherko Kuemmel Ulrike Nitz Nadia Harbeck Hans Kreipe Matthias Christgen Source Type: research
Adenoid ameloblastoma harbors beta-catenin mutations
Modern Pathology, Published online: 15 July 2022; doi:10.1038/s41379-022-01125-4Adenoid ameloblastoma harbors beta-catenin mutations (Source: Modern Pathology)
Source: Modern Pathology - July 15, 2022 Category: Pathology Authors: Victor Coutinho Bastos Bruna Pizziolo Coura Let ícia Martins Guimarães Bianca Gomes Fernandes Alexander Chak-Lam Chan Pablo Agustin Vargas Luciana Bastos-Rodrigues Luiz Armando De Marco John Hellstein Selvam Thavaraj John M. Wright Edward William Odell Source Type: research
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab
Modern Pathology, Published online: 15 July 2022; doi:10.1038/s41379-022-01119-2Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab (Source: Modern Pathology)
Source: Modern Pathology - July 15, 2022 Category: Pathology Authors: Vipul Baxi George Lee Chunzhe Duan Dimple Pandya Daniel N. Cohen Robin Edwards Han Chang Jun Li Hunter Elliott Harsha Pokkalla Benjamin Glass Nishant Agrawal Abhik Lahiri Dayong Wang Aditya Khosla Ilan Wapinski Andrew Beck Michael Montalto Source Type: research
